Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lebas

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Revue Medicale De Liege|January 26, 2019
[Treatment of mucocutaneous toxicity of target therapy in oncology]Th Damsin, J Collignon, E Lebas, et al.
Acta Paediatrica Scandinavica|January 1, 1984
Complex chromosomal rearrangement in a mentally retarded boy without gross dysmorphic stigmataJ P Fryns, A Kleczkowska, E Lebas, et al.
Revue Medicale De Liege|September 3, 2021
[Köbner's phenomenon in dermatology]G Giet, Y Senterre, E Lebas, et al.
Annales De Biologie Clinique|February 1, 2007
[Free and intracellular bacteria on peripheral blood smears: an uncommon situation related to an adverse prognosis]J Gérard, E Lebas, A Godon, et al.
Revue Medicale De Liege|June 14, 2012
[Cutaneous adverse effects of TNFalpha antagonists]V Failla, M Sabatiello, E Lebas, et al.
Revue Medicale De Liege|June 5, 2020
[Actual treatments of psoriasis : from etanercept to anti-IL17 and anti-IL23 antagonists]F Libon, E Lebas, L El Hayderi, et al.
Clinical Genetics|November 1, 1977
Short stature, craniofacial dysmorphism and dento-skeletal abnormalities in a large kindred. A variant of K.B.G. syndrome or a new mental retardation syndromeC Parloir, J P Fryns, J Deroover, et al.
Revue Medicale De Liege|August 3, 2019
[Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab]L Vanhakendover, E Lebas, F Libon, et al.
Revue Medicale De Liege|June 3, 2021
[Melanoma : the patient's care pathway. From diagnosis to therapy]G Absil, T Damsin, E Lebas, et al.
Nature Medicine|August 14, 2019
Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distributionT Doan, A Hinterwirth, L Worden, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Revue Medicale De Liege|January 26, 2019
[Treatment of mucocutaneous toxicity of target therapy in oncology]Th Damsin, J Collignon, E Lebas, et al.
Acta Paediatrica Scandinavica|January 1, 1984
Complex chromosomal rearrangement in a mentally retarded boy without gross dysmorphic stigmataJ P Fryns, A Kleczkowska, E Lebas, et al.
Revue Medicale De Liege|September 3, 2021
[Köbner's phenomenon in dermatology]G Giet, Y Senterre, E Lebas, et al.
Annales De Biologie Clinique|February 1, 2007
[Free and intracellular bacteria on peripheral blood smears: an uncommon situation related to an adverse prognosis]J Gérard, E Lebas, A Godon, et al.
Revue Medicale De Liege|June 14, 2012
[Cutaneous adverse effects of TNFalpha antagonists]V Failla, M Sabatiello, E Lebas, et al.
Revue Medicale De Liege|June 5, 2020
[Actual treatments of psoriasis : from etanercept to anti-IL17 and anti-IL23 antagonists]F Libon, E Lebas, L El Hayderi, et al.
Clinical Genetics|November 1, 1977
Short stature, craniofacial dysmorphism and dento-skeletal abnormalities in a large kindred. A variant of K.B.G. syndrome or a new mental retardation syndromeC Parloir, J P Fryns, J Deroover, et al.
Revue Medicale De Liege|August 3, 2019
[Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab]L Vanhakendover, E Lebas, F Libon, et al.
Revue Medicale De Liege|June 3, 2021
[Melanoma : the patient's care pathway. From diagnosis to therapy]G Absil, T Damsin, E Lebas, et al.
Nature Medicine|August 14, 2019
Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distributionT Doan, A Hinterwirth, L Worden, et al.
Pageof 3